Yong Z. Wei
155 Hanzhong Road
Nanjing, 210006, China
Nanjing, 210006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Preliminary feasibility of SHURUI single-port robot-assisted radical cystectomy with exploratory comparison to a contemporaneous da Vinci Xi single-port cohort.
Journal: Minerva urology and nephrology
Published: July 13, 2026
EP300-Mediated MTF1-K218 Lactylation Buffers AR-Driven Copper Overload to Suppress Cuproptosis in Castration-Resistant Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 07, 2026
Analysis of transurethral water vapor thermal therapy for the treatment of benign prostatic hyperplasia
Journal: Zhonghua nan ke xue = National journal of andrology
Published: September 05, 2025
Decoding lactylation landscapes: Metabolic-epigenetic crosstalk through histone/non-histone modifications as drivers of disease progression and treatment resistance.
Journal: Biochemical and biophysical research communications
Published: August 15, 2025
Integrative molecular-radiopathomic characterization of AIRE-driven immune subtypes in bladder cancer.
Journal: NPJ digital medicine
Published: August 04, 2025
Current Applications and Future Prospects of Laparoendoscopic Single-Site Surgery in Urology
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: July 18, 2025
N6-methyladenosine-modified circLPAR3 drives docetaxel resistance in prostate cancer by suppressing ferroptosis through the PCBP2/CHAC1 axis.
Journal: Genes & diseases
Published: April 28, 2025
Integrative transcriptomic profiling reveals subtype-specific therapeutic vulnerabilities and resistance mechanisms in prostate cancer.
Journal: BMC cancer
Published: April 22, 2025
Global patterns and burden of soft tissue and extraosseous sarcomas: trends from 1990 to 2021.
Journal: BMC cancer
Published: January 31, 2025
N6-methyladenosine-modified RNF220 induces cisplatin resistance and immune escape via regulating PDE10A K48-linked ubiquitination in bladder cancer.
Journal: Biochemical pharmacology
Published: December 29, 2024
Identification of E3 ubiquitin ligase-based molecular subtypes and prognostic signature regarding prognosis and immune landscape in bladder cancer.
Journal: Cancer cell international
Published: December 04, 2024
Last Updated: 09/26/2026